hotspot -WSS

hotspot

author：Wikipedia 2025-08-06 04:47:41 - browse：7

Are venture capitalists OK? Are bolt-ons good for business? And when is it safe to say someone overpaid?

We cover all that and more this week on “The Readout LOUD,” STAT’s biotech podcast. We discuss how biotech’s downturn has made life difficult not just for startups but also the VCs they rely on for much-needed funding. We also take a look at Gilead Sciences’ struggle to turn itself into an oncology company and the latest biotech to get bought out by a major pharma firm.

For more on what we cover, here’s more on Gilead; here’s the news on Inhibrx; here’s the latest on biotech venture capital; here’s where you can find episodes of Color Code; here’s where you can subscribe to the First Opinion Podcast; and here’s where you can subscribe to our biotech newsletter, The Readout.

Be sure to sign up on Apple Podcasts, Spotify, Stitcher, TuneIn, or wherever you get your podcasts.

And if you have any feedback for us — topics to cover, guests to invite, vocal tics to cease — you can email [email protected].

Previous article： Heart attack and stroke risk calculators need revising
Next article： Global childhood vaccinations edge closer to pre

hotspot

WSS

UnitedHealth’s Q3 profit jumps as medical costs rise more slowly

Europe sees delivery challenges ahead on Alzheimer's therapies

4 killed in mass shooting in Georgia, shooter remains on the loose: Police

J&J expands global access to TB drug amid advocacy campaign

Takeaways from AdvaMed, the largest medical devices conference

Peter Marks talks Operation Warp Speed for Rare Diseases

entertainment

hotspot

explore

Moonlake's readout produced a cash windfall. Risks remain

Mike Pence clashes with Tucker Carlson in Iowa

Duchenne breakthrough therapy leaves behind pioneering families

What the Wegovy shortage looks like for doctors — and for patients

Food as medicine: CMS rules hamper 'prescribing' of fruits, veggies

Celiac disease study examines precisely how gluten triggers injury

Anesthesiologist group: stop taking Ozempic before surgery

Takeaways from AdvaMed, the largest medical devices conference

23andMe had bad news about my health. I wish a person had delivered it

Grail faces three suits alleging harassment, retaliation

knowledge

Massive project maps cells in human brain in unprecedented detail

There’s no way to know how good AI health technologies are

Involuntary treatment for addiction doesn't work

STAT Readout Newsletter: Today in biotech, life science news

Researchers CRISPR chickens in bid to protect them from bird flu

Georgia court denies Trump's request to quash DA's 2020 election probe

leisure time

hotspot

explore

knowledge